These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8136604)

  • 1. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies.
    Heddle NM
    Transfus Med Rev; 1994 Jan; 8(1):15-28. PubMed ID: 8136604
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian Red Cross Society symposium on leukodepletion: report of proceedings.
    Freedman JJ; Blajchman MA; McCombie N
    Transfus Med Rev; 1994 Jan; 8(1):1-14. PubMed ID: 7907899
    [No Abstract]   [Full Text] [Related]  

  • 3. The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.
    Heddle NM; Blajchman MA
    Blood; 1995 Feb; 85(3):603-6. PubMed ID: 7833464
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
    Cid J; Ramiro L; Escoda L; Llorente A
    Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions.
    Vamvakas EC
    Transfus Med Rev; 1998 Oct; 12(4):258-70. PubMed ID: 9798269
    [No Abstract]   [Full Text] [Related]  

  • 6. Time to rethink clinically important outcomes in platelet transfusion trials.
    Heddle NM; Arnold DM; Webert KE
    Transfusion; 2011 Feb; 51(2):430-4. PubMed ID: 21309780
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunologic, and technical factors affecting recovery of platelet count after platelet transfusion.
    Inverardi D; Bocchio C; Rossi L; Mazzucco L; De Paoli L; Borzini P
    Haematologica; 2002 Aug; 87(8):893-4. PubMed ID: 12161372
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia.
    Sintnicolaas K; Vriesendorp HM; Sizoo W; Stenfert Kroese WF; Haije WG; Hop WC; Abels J; Löwenberg B
    Lancet; 1981 Apr; 1(8223):750-4. PubMed ID: 6110956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
    Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants.
    Sparger KA; Assmann SF; Granger S; Winston A; Christensen RD; Widness JA; Josephson C; Stowell SR; Saxonhouse M; Sola-Visner M
    JAMA Pediatr; 2016 Jul; 170(7):687-94. PubMed ID: 27213618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of leukodepleted platelet transfusion].
    Ishida A; Handa M
    Nihon Rinsho; 1997 Sep; 55(9):2385-91. PubMed ID: 9301305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical aspects of platelet transfusion].
    Julia A; Massuet L; Pujol M; Martín Vega C
    Sangre (Barc); 1985; 30(4-B):548-56. PubMed ID: 3909466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indication for platelet transfusion in patients with haematological diseases: less is more].
    Wandt H
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1877-9. PubMed ID: 20842610
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial.
    van de Weerdt EK; Biemond BJ; Zeerleder SS; van Lienden KP; Binnekade JM; Vlaar APJ;
    Trials; 2018 Feb; 19(1):127. PubMed ID: 29463280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-poor blood: arguments and guidelines.
    Brand A
    Vox Sang; 1994; 67 Suppl 3():129-31. PubMed ID: 7975475
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of severe thrombocytopenia in alloimmunized, transfusion-refractory patients.
    Ornstein DL; Mortara KL; Smith MB; Ririe DW; Shaughnessy PJ; Bickford DJ; Kissack BL
    Mil Med; 2001 Mar; 166(3):269-74. PubMed ID: 11263033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability.
    van Marwijk Kooy M; van Prooijen HC; Borghuis L; Moes M; Akkerman JW
    Transfusion; 1990 Jan; 30(1):34-8. PubMed ID: 2296787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.